TITLE

Jaundice During Treatment with an Oral Contraceptive Lyndiol

AUTHOR(S)
Cullberg, Göran; Lundström, Rolf; Stenram, Unne
PUB. DATE
March 1965
SOURCE
British Medical Journal;3/13/1965, Vol. 1 Issue 5436, p695
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64057998

 

Related Articles

  • Effect of Oral Contraceptives on Leukocyte Count in Hemophiliacs. Kiran, Ozden; Urkuten, Meral; Ozsoylu, Sinasi // Clinical Pediatrics;Nov1970, Vol. 9 Issue 11, p656 

    The authors discusses the effect of the oral contraceptive Lyndiol 2.5 on leukocyte count in hemophiliacs in a treatment experiment. Lyndiol was given daily to more than 75 hemophilic childhood patients. After nine months of use, a neutrophilic leukocytosis developed. The use of the drug...

  • Follicle Growth is FSH Dose Dependent Despite Low LH Levels.  // Fertility Weekly;7/29/2002, p6 

    The spontaneous recovery of pituitary-ovarian activity during the pill-free period following the use of low-dose oral contraceptives was compared to exogenous recombinant follicle stimulating hormone (FSH) administration during high-dose combined oral contraceptive use. The study authors sought...

  • Pruritus of Pregnancy and Jaundice Induced by Oral Contraceptives. Medline, A.; Ptak, T.; Gryfe, A.; Blenkinsop, B. // American Journal of Gastroenterology;Feb1976, Vol. 65 Issue 2, p156 

    This article presents a young girl who developed jaundice while on oral contraceptives. A most significant feature in this particular patient's history was the severe pruritus she developed during a previous gestation. This combination of events should alert physicians to the possible diagnosis....

  • Ethinylestradiol/gestodene.  // Reactions Weekly;3/6/2010, Issue 1291, p23 

    The article describes the case of a woman who developed deep vein thrombosis during treatment with ethinylestradiol and gestodene for oral contraception.

  • Centchroman.  // Reactions Weekly;11/12/2011, Issue 1377, p12 

    The article describes the case of a woman who developed endometrial changes during treatment with the oral contraceptive centchroman.

  • Oral contraceptive approved for moderate acne treatment.  // Cosmetic Surgery Times;Oct2001, Vol. 5 Issue 9, p34 

    Examines the usage of oral contraceptive for moderate acne treatment.

  • Ethinylestradiol/chlormadinone.  // Reactions Weekly;10/8/2011, Issue 1372, p18 

    The article describes the case of a 22-year-old woman who developed hemicentral retinal artery occlusion during treatment with an ethinylestradiol chlormadinone oral contraceptive.

  • Drospirenone/ethinylestradiol/norethisterone.  // Reactions Weekly;10/13/2012, Issue 1423, p22 

    The article describes the cases of two patients who developed pulmonary veno-occlusive disease (PVOD) during treatment with oral contraceptives (OCs).

  • THE EFFECTS OF ORAL CONTRACEPTIVE INDUCED NUTRITION DEPLETIONS AND ITS CONSEQUENCES. Martin, Brett R.; Richardson, Daniel L. // Original Internist;Jun2011, Vol. 18 Issue 2, p45 

    The article discusses the effects and consequences of oral contraceptive induced nutrition depletions as the contraceptives disrupt the digestion and absorption of nutrients in the gastrointestinal tract. Oral contraceptives increase the risk of developing thromboembolic vascular diseases,...

  • Evaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder. Megivern, Deborah // Journal of Women's Health & Gender-Based Medicine;Mar2002, Vol. 11 Issue 2, p95 

    Presents a letter to the editor about the oral contraceptive in the treatment of premenstrual dysphoric disorder.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics